Patents by Inventor Gerhard Frisch
Gerhard Frisch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10568511Abstract: A handheld diabetes management device for managing blood glucose test data and continuous glucose monitoring data includes a port configured to receive a test strip, a wireless transceiver, a communications processor, and a user interface processor. The communications processor communicates with the wireless transceiver to periodically collect glucose measurement data from a continuous glucose monitoring device and to store the glucose measurement data in a first data storage module. The communications processor is operable to consume electrical power at a first rate. The user interface processor communicates with the communication processor to receive the glucose measurement data and operable to display the glucose measurement data on the device. The communications processor operates asynchronously from operation of the user interface processor to collect the glucose measurement data and the user interface processor operates to consume electrical power at a second rate that is higher than the first rate.Type: GrantFiled: August 31, 2016Date of Patent: February 25, 2020Assignee: Roche Diabetes Care, Inc.Inventors: Timothy P. Engelhardt, Gerhard Frisch, Robert E. Reinke, Wilfried Schmidt, Michael Schoemaker, Uwe Wittmann
-
Patent number: 10289652Abstract: A method for operating measuring equipment for detecting at least one analyte in a bodily fluid by means of at least one continuously measuring blood glucose sensor. At least one calibration method is carried out for the prospective calibration of the measuring equipment. At least three calibration points are detected in the calibration method, wherein each calibration point comprises at least one measurement signal from the measuring equipment and at least one reference value of an associated reference measurement. A plurality of possible slopes are established between the calibration points. At least one robust estimation method, more particularly using a formation of at least one median, is used to determine at least one probable slope from the plurality of possible slopes. Furthermore, at least one measurement is carried out.Type: GrantFiled: November 18, 2015Date of Patent: May 14, 2019Assignee: Roche Diabetes Care, Inc.Inventors: Nikolaus Schmitt, Gerhard Frisch
-
Patent number: 9610127Abstract: A protective container for holding a reusable control part of a transcutaneous sensor system for detecting at least one analyte in a bodily fluid is disclosed. The control part includes at least one coupling, which has at least one sensor coupling for connection to at least one transcutaneous sensor. The protective container has at least one container housing. The control part can be held in the container housing. The container housing is adapted to shield the control part from environmental influences. The container housing also has at least one connector which can be connected to the coupling and seals the latter in a media-tight fashion.Type: GrantFiled: June 30, 2014Date of Patent: April 4, 2017Assignee: ROCHE DIABETES CARE, INC.Inventors: Wolfgang Heck, Bernd Roesicke, Gerhard Frisch
-
Publication number: 20160367139Abstract: A handheld diabetes management device for managing blood glucose test data and continuous glucose monitoring data includes a port configured to receive a test strip, a wireless transceiver, a communications processor, and a user interface processor. The communications processor communicates with the wireless transceiver to periodically collect glucose measurement data from a continuous glucose monitoring device and to store the glucose measurement data in a first data storage module. The communications processor is operable to consume electrical power at a first rate. The user interface processor communicates with the communication processor to receive the glucose measurement data and operable to display the glucose measurement data on the device. The communications processor operates asynchronously from operation of the user interface processor to collect the glucose measurement data and the user interface processor operates to consume electrical power at a second rate that is higher than the first rate.Type: ApplicationFiled: August 31, 2016Publication date: December 22, 2016Inventors: Timothy P. ENGELHARDT, Gerhard FRISCH, Robert E. REINKE, Wilfried SCHMIDT, Michael SCHOEMAKER, Uwe WITTMANN
-
Patent number: 9504411Abstract: A handheld diabetes management device for managing blood glucose test data and continuous glucose monitoring data includes a port configured to receive a test strip, a wireless transceiver, a communications processor, and a user interface processor. The communications processor communicates with the wireless transceiver to periodically collect glucose measurement data from a continuous glucose monitoring device and to store the glucose measurement data in a first data storage module. The communications processor is operable to consume electrical power at a first rate. The user interface processor communicates with the communication processor to receive the glucose measurement data and operable to display the glucose measurement data on the device. The communications processor operates asynchronously from operation of the user interface processor to collect the glucose measurement data and the user interface processor operates to consume electrical power at a second rate that is higher than the first rate.Type: GrantFiled: August 28, 2012Date of Patent: November 29, 2016Assignee: Roche Diabetes Care, Inc.Inventors: Timothy P. Engelhardt, Gerhard Frisch, Robert E. Reinke, Wilfried Schmidt, Michael Schoemaker, Uwe Wittmann
-
Publication number: 20160070675Abstract: A method for operating measuring equipment for detecting at least one analyte in a bodily fluid by means of at least one continuously measuring blood glucose sensor. At least one calibration method is carried out for the prospective calibration of the measuring equipment. At least three calibration points are detected in the calibration method, wherein each calibration point comprises at least one measurement signal from the measuring equipment and at least one reference value of an associated reference measurement. A plurality of possible slopes are established between the calibration points. At least one robust estimation method, more particularly using a formation of at least one median, is used to determine at least one probable slope from the plurality of possible slopes. Furthermore, at least one measurement is carried out.Type: ApplicationFiled: November 18, 2015Publication date: March 10, 2016Inventors: Nikolaus Schmitt, Gerhard Frisch
-
Patent number: 9222951Abstract: A method for operating measuring equipment for detecting an analyte in a bodily fluid by means of a continuously measuring blood glucose sensor. A calibration method is carried out for the prospective calibration of the measuring equipment. At least three calibration points are detected in the calibration method, wherein each calibration point comprises a measurement signal from the measuring equipment and a reference value of an associated reference measurement. A plurality of possible slopes are established between the calibration points. At least one robust estimation method using a formation of at least one median is used to determine a probable slope from the plurality of possible slopes. Furthermore, a measurement is carried out. During the measurement and using the probable slope, a concentration of the analyte in the bodily fluid is deduced from a measurement signal from the measuring equipment and the probable slope.Type: GrantFiled: February 27, 2012Date of Patent: December 29, 2015Assignee: Roche Diabetes Care, Inc.Inventors: Nikolaus Schmitt, Gerhard Frisch
-
Patent number: 8977505Abstract: A method is provided for controlling a hand-held analysis device for analyzing a body fluid in which in each case at least one test means for single use is automatically provided in consecutive measuring cycles by means of a control device where each measuring cycle in a measuring mode of the control device is triggered by a start actuation. According to the invention it is proposed that a defined control intervention puts the control device into a maintenance mode in which the automatic provision of a test means is prevented.Type: GrantFiled: December 21, 2010Date of Patent: March 10, 2015Assignee: Roche Diagnostics Operations, Inc.Inventors: Karl Miltner, Thorsten Baeter, Gerhard Frisch, Sebastian Liedtke, Wilfried Schmid, Wolfgang Heck
-
Patent number: 8901041Abstract: Liquid aqueous formulations of water-soluble active crop protectant ingredients which comprise (a) one or more water-soluble active ingredients (type (a) ingredients), (b) if desired, one or more water-insoluble active ingredients (type (b) ingredients), (c) if desired, polar organic solvents, (d) anionic surfactants, (e) if desired, nonionic, cationic and/or zwitterioinic surfactants, (f) silicone-based defoamers from the group of the linear polydimethylsiloxanes having an average dynamic viscosity, measured at 25° C., in the range from 1000 to 8000 mPas, and containing silica, (g) if desired, other, customary formulation assistants, and (h) water are suitable as low-foam formulations for application in crop protection. Also possible is the use of the corresponding active-ingredient-free adjuvant formulations in a tank mix with or in split application with active-ingredient formulations.Type: GrantFiled: May 27, 2005Date of Patent: December 2, 2014Assignee: Bayer Intellectual Property GmbHInventors: Gerhard Frisch, Gerhard Schnabel, Janine Rude
-
Publication number: 20140316223Abstract: A protective container for holding a reusable control part of a transcutaneous sensor system for detecting at least one analyte in a bodily fluid is disclosed. The control part includes at least one coupling, which has at least one sensor coupling for connection to at least one transcutaneous sensor. The protective container has at least one container housing. The control part can be held in the container housing. The container housing is adapted to shield the control part from environmental influences. The container housing also has at least one connector which can be connected to the coupling and seals the latter in a media-tight fashion.Type: ApplicationFiled: June 30, 2014Publication date: October 23, 2014Inventors: Wolfgang Heck, Bernd Roesicke, Gerhard Frisch
-
Patent number: 8783102Abstract: A protective container for holding a reusable control part of a transcutaneous sensor system for detecting at least one analyte in a bodily fluid is disclosed. The control part includes at least one coupling, which has at least one sensor coupling for connection to at least one transcutaneous sensor. The protective container has at least one container housing. The control part can be held in the container housing. The container housing is adapted to shield the control part from environmental influences. The container housing also has at least one connector which can be connected to the coupling and seals the latter in a media-tight fashion.Type: GrantFiled: December 17, 2010Date of Patent: July 22, 2014Assignee: Roche Diagnostics Operations, Inc.Inventors: Wolfgang Heck, Bernd Roesicke, Gerhard Frisch
-
Publication number: 20140172449Abstract: A diabetes management system having a reliable data management scheme is disclosed. The system comprises a plurality of devices, each device performing a different function relating to treatment of diabetes. Each device has a device identifier and each device generates data records relating to the function of the device. Each device includes a metadata generator configured to generate a metadata tag for a data record generated by the device. A metadata tag includes the device identifier of the corresponding device, a record identifier, and a source identifier indicating whether the record was originated by a human or the device. The system further includes a diabetes management device in communication with the plurality of devices and configured to manage records received from the plurality of devices.Type: ApplicationFiled: February 25, 2014Publication date: June 19, 2014Applicants: Roche Diagnostics International AG, Roche Diagnostics Operations, Inc.Inventors: Robert E. Reinke, Phillip E. Pash, James R. Long, Guido Konrad, Erich Imhof, Gerhard Frisch
-
Patent number: 8706520Abstract: A diabetes management system having a reliable data management scheme is disclosed. The system comprises a plurality of devices, each device performing a different function relating to treatment of diabetes. Each device has a device identifier and generates data records. Each device includes a metadata generator configured to generate a metadata tag for a data record generated by the device. A metadata tag includes the device identifier of the corresponding device, a record identifier, and a source identifier indicating whether the record was originated by a human or the device. The system further includes a diabetes management device. When a device generates a new record, the metadata generator generates a new record identifier and a new metadata tag based on the new record identifier and the device identifier of the device. The first device propagates the new record and the new metadata tag to the diabetes management device.Type: GrantFiled: October 15, 2010Date of Patent: April 22, 2014Assignees: Roche Diagnostics Operations, Inc., Roche Diagnostics International AGInventors: Robert E. Reinke, Phillip E. Pash, James R. Long, Guido Konrad, Erich Imhof, Gerhard Frisch
-
Publication number: 20140066735Abstract: A handheld diabetes management device for managing blood glucose test data and continuous glucose monitoring data includes a port configured to receive a test strip, a wireless transceiver, a communications processor, and a user interface processor. The communications processor communicates with the wireless transceiver to periodically collect glucose measurement data from a continuous glucose monitoring device and to store the glucose measurement data in a first data storage module. The communications processor is operable to consume electrical power at a first rate. The user interface processor communicates with the communication processor to receive the glucose measurement data and operable to display the glucose measurement data on the device. The communications processor operates asynchronously from operation of the user interface processor to collect the glucose measurement data and the user interface processor operates to consume electrical power at a second rate that is higher than the first rate.Type: ApplicationFiled: August 28, 2012Publication date: March 6, 2014Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventors: Timothy P. Engelhardt, Gerhard Frisch, Robert E. Reinke, Wilfried Schmidt, Michael Schoemaker, Uwe Wittmann
-
Publication number: 20120191362Abstract: A method for operating measuring equipment for detecting an analyte in a bodily fluid by means of a continuously measuring blood glucose sensor. A calibration method is carried out for the prospective calibration of the measuring equipment. At least three calibration points are detected in the calibration method, wherein each calibration point comprises a measurement signal from the measuring equipment and a reference value of an associated reference measurement. A plurality of possible slopes are established between the calibration points. At least one robust estimation method, using a formation of at least one median is used to determine a probable slope from the plurality of possible slopes. Furthermore, a measurement is carried out. During the measurement and using the probable slope, a concentration of the analyte in the bodily fluid is deduced from a measurement signal from the measuring equipment and the probable slope.Type: ApplicationFiled: February 27, 2012Publication date: July 26, 2012Inventors: Nikolaus Schmitt, Gerhard Frisch
-
Publication number: 20120165639Abstract: A method for storing data at a continuous glucose monitor is presented. The method includes measuring the blood glucose level of the patient. The method also includes receiving a plurality of physical attributes related to the glucose level of the patient. The method further includes determining calibration data based on the measured blood glucose level and at least one of the plurality of physical attribute samples, the calibration data configured to allow the handheld diabetes managing device to determine the estimated glucose level of the patient based on the plurality of physical attribute samples. Finally, the method includes transmitting the calibration data from the handheld diabetes managing device to the continuous glucose monitor for storage at the continuous glucose monitor. The calibration data and plurality of physical attribute samples can be retrieved by a separate device to determine an estimated glucose level of the patient.Type: ApplicationFiled: December 22, 2010Publication date: June 28, 2012Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventors: Timothy Peter Engelhardt, Guenter Handwerker, Mark Nierzwick, Gerhard Frisch, Phillip E. Pash
-
Publication number: 20120095774Abstract: A diabetes management system having a reliable data management scheme is disclosed. The system comprises a plurality of devices, each device performing a different function relating to treatment of diabetes. Each device has a device identifier and each device generates data records relating to the function of the device. Each device includes a metadata generator configured to generate a metadata tag for a data record generated by the device. A metadata tag includes the device identifier of the corresponding device, a record identifier, and a source identifier indicating whether the record was originated by a human or the device. The system further includes a diabetes management device in communication with the plurality of devices and configured to manage records received from the plurality of devices.Type: ApplicationFiled: October 15, 2010Publication date: April 19, 2012Applicant: ROCHE DIAGNOSTICS OPERATIONS, INC.Inventors: Robert E. Reinke, Phillip E. Pash, James R. Long, Guido Konrad, Erich Imhof, Gerhard Frisch
-
Patent number: 8110529Abstract: Liquid aqueous formulations of water-soluble active crop protectant ingredients which comprise (a) one or more water-soluble active crop protectant ingredients (type (a) ingredients), (b) one or more water-dispersed active crop protectant ingredients (type (b) ingredients), (c) one or more surfactants from the class of the polyacrylic acid derivatives, (d) one or more aluminum silicates as stabilizer(s), (e) if desired, further anionic or nonionic, cationic and/or zwitterionic surfactants, (f) if desired, other customary formulation assistants, and (g) water are suitable as stable coformulations for use in crop protection.Type: GrantFiled: May 27, 2005Date of Patent: February 7, 2012Assignee: Bayer Cropscience AGInventors: Gerhard Frisch, Thomas Maier
-
Publication number: 20120004852Abstract: A method is provided for controlling a hand-held analysis device for analyzing a body fluid in which in each case at least one test means for single use is automatically provided in consecutive measuring cycles by means of a control device where each measuring cycle in a measuring mode of the control device is triggered by a start actuation. According to the invention it is proposed that a defined control intervention puts the control device into a maintenance mode in which the automatic provision of a test means is prevented.Type: ApplicationFiled: December 21, 2010Publication date: January 5, 2012Inventors: Karl Miltner, Thorsten Baeter, Gerhard Frisch, Sebastian Liedtke, Wilfried Schmid, Wolfgang Heck
-
Patent number: 8076268Abstract: Liquid formulations containing herbicidal actives from the group of HPPD inhibitors, dialkyl sulfosuccinates, surfactants and solvents are provided. The present invention relates to liquid formulations comprising: A) one or more HPPD inhibitors, B) one or more dialkyl sulfosuccinates, C) one or more further surfactants, D) one or more solvents, E) further auxiliaries and additives, and F) one or more non-A) agrochemical actives. The liquid formulations are suitable for use in the field of crop protection.Type: GrantFiled: November 16, 2006Date of Patent: December 13, 2011Assignee: Bayer CropScience AGInventors: Gerhard Schnabel, Detlev Haase, Gerhard Frisch, Martin Bommel